Docs who take pharma dollars more likely to prescribe inappropriate drugs: study

Oncologists who receive payments from industry may be more likely to prescribe non-recommended and low-value treatments. That is the assertion of a paper published in The BMJ that analyzed data on claims and physician payments to assess whether drugmakers have a negative influence on prescribing habits.